Pyrrolo[1,2-f]triazines as JAK2 inhibitors: Achieving potency and selectivity for JAK2 over JAK3.
Harikrishnan, L.S., Kamau, M.G., Wan, H., Inghrim, J.A., Zimmermann, K., Sang, X., Mastalerz, H.A., Johnson, W.L., Zhang, G., Lombardo, L.J., Poss, M.A., Trainor, G.L., Tokarski, J.S., Lorenzi, M.V., You, D., Gottardis, M.M., Baldwin, K.F., Lippy, J., Nirschl, D.S., Qiu, R., Miller, A.V., Khan, J., Sack, J.S., Purandare, A.V.(2011) Bioorg Med Chem Lett 21: 1425-1428
- PubMed: 21282055 
- DOI: https://doi.org/10.1016/j.bmcl.2011.01.022
- Primary Citation of Related Structures:  
3Q32 - PubMed Abstract: